About Luma MDX
Luma MDX sells an AI platform to oncology and multi-specialty medical practices. It has six modules, and a practice can start with one. The modules draft visit notes, queue prior authorizations (insurer approvals) and referrals from the note, and answer staff questions from a patient's chart. Other modules use an AI voice to answer patient calls, let doctors prescribe from any device and show daily financial dashboards. The company sets up each practice with its own implementation specialists and reviews usage with the practice every quarter.
Luma MDX is based in Augusta, Georgia. It built the software inside Augusta Oncology Multi-Specialty Clinic, where it has run live since October 2025. The software cut documentation time by 80% and saves each physician one to two hours a day. It also answers every patient call. David Squires, MD, a medical oncologist at the clinic since 2003, is chief executive. Samuel Squires, known as Sam, is chief operating officer.
Funding Rounds (SEC Form D)
| First sale | Filed with SEC | Amount sold | Investors | Avg. check | Terms | Filing |
|---|---|---|---|---|---|---|
| Oct 27, 2026 | Oct 27, 2026 | $100,000of $5.0M target | 1 | $100K | Simple Agreement for Future Equity (SAFE)Rule 506(b) | Form D ↗ |
First sale is the date the first investor in the offering committed to invest. Companies must file Form D within 15 days of that date, so filing dates run later.
Why Investors Backed Luma MDX
Luma MDX sells AI software to oncology and multi-specialty practices. Its pitch is that doctors lose time to notes, insurer approvals and missed patient calls, and that one platform can reduce all three. Its leaders built the software inside a working oncology clinic, where it has run live since October 2025. The website does not name any investors.
The problem it targets
Luma MDX's case is that oncology practices face four problems. Doctors lose time writing notes. Prior authorizations, which are insurer approvals needed before some care, turn chaotic. Patient calls go unanswered. Older electronic records cannot follow an oncology patient's timeline. The first problem is widespread: many clinicians say they spend more time documenting than talking with patients, according to the Commonwealth Fund. It built the software inside a working oncology practice to fix these problems one module at a time.
What the product does
The platform has six modules. Clinical Note Intelligence listens to the visit, drafts the note and merges it with the prior note to keep a running summary of the patient. Workflow Intelligence queues prior authorizations, referrals and scheduling from the note. Ask Luma answers staff questions from the chart and drafts appeal letters to insurers. The AI call center answers patient calls and routes them to nurses, schedulers or billing staff. Two more modules cover prescribing from any device and daily financial dashboards. It runs on Microsoft Azure and keeps patient data in a HIPAA-compliant data vault.
Progress so far
The platform has run live at Augusta Oncology Multi-Specialty Clinic since October 2025. It cut documentation time by 80%, answered 100% of calls and saved one to two hours per physician per day. It also expects practices to earn back their spending within 90 days. The website does not explain how it measured these figures, and it names no other customers.
How the market is moving
Community oncology practices are adopting AI. At the Community Oncology Alliance conference in April 2026, two panelists called ambient scribes an early AI win, according to AJMC. These tools listen to a visit and draft the note. The Commonwealth Fund wrote in May 2026 that more than 60 AI scribing tools are in use in health care. Phone agents are spreading too. Canopy's AI phone operator handles overflow calls for Highlands Oncology. A Canopy presenter said it took nearly 20% of all incoming calls on a recent busy Monday, according to AJMC.
We wrote this summary from public statements by Luma MDX and its investors. It is not investment advice.
Luma MDX in the News
Leadership Team
Executive officers and directors listed on Luma MDX's Form D filed Oct 27, 2026.
Sources
- SECLuma MDX Solutions, Inc. filing history
- Company siteAbout & Leadership page on lumamdx.com
- Company sitePlatform overview on lumamdx.com
- Company siteClinical Note Intelligence page on lumamdx.com
- Company siteWorkflow Intelligence page on lumamdx.com
- Company siteAsk Luma page on lumamdx.com
- Company siteAI Call Center page on lumamdx.com
- Company siteePrescribe page on lumamdx.com
- Company siteAnalytics & Dashboards page on lumamdx.com
- Company siteHow We Work page on lumamdx.com
- Company siteTrust & Security page on lumamdx.com
- Company siteContact page on lumamdx.com
- Company sitePrivacy policy on lumamdx.com
- PressAJMC on AI at the Community Oncology Alliance conference (May 1, 2026)
- ResearchCommonwealth Fund blog on AI ambient scribing (May 13, 2026)
- Other company siteCommure blog on ambient AI for oncology (June 15, 2026)